These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15448480)

  • 1. Roles of chemokines in ocular allergy and possible therapeutic strategies.
    Miyazaki D; Nakamura T; Komatsu N; Nawata N; Ikeda Y; Inoue Y; Higashi H; Ono SJ
    Cornea; 2004 Nov; 23(8 Suppl):S48-54. PubMed ID: 15448480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
    Erin EM; Williams TJ; Barnes PJ; Hansel TT
    Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):201-14. PubMed ID: 14561201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in allergic conjunctivitis.
    Erdinest N; London N; Solomon A
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):516-527. PubMed ID: 32739979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.
    Solomon A; Pe'er J; Levi-Schaffer F
    Curr Opin Allergy Clin Immunol; 2001 Oct; 1(5):477-82. PubMed ID: 11964730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
    Elsner J; Escher SE; Forssmann U
    Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva.
    Nakamura T; Ohbayashi M; Toda M; Hall DA; Horgan CM; Ono SJ
    Immunol Res; 2005; 33(3):213-21. PubMed ID: 16461999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis.
    Huaux F; Gharaee-Kermani M; Liu T; Morel V; McGarry B; Ullenbruch M; Kunkel SL; Wang J; Xing Z; Phan SH
    Am J Pathol; 2005 Dec; 167(6):1485-96. PubMed ID: 16314464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.
    Fukagawa K; Okada N; Fujishima H; Nakajima T; Tsubota K; Takano Y; Kawasaki H; Saito H; Hirai K
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):58-62. PubMed ID: 11773013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
    Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
    J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells.
    de Paulis A; De Palma R; Di Gioia L; Carfora M; Prevete N; Tosi G; Accolla RS; Marone G
    J Immunol; 2000 Dec; 165(12):7171-9. PubMed ID: 11120849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic conjunctivitis: a comprehensive review of the literature.
    La Rosa M; Lionetti E; Reibaldi M; Russo A; Longo A; Leonardi S; Tomarchio S; Avitabile T; Reibaldi A
    Ital J Pediatr; 2013 Mar; 39():18. PubMed ID: 23497516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of eotaxin and related CC chemokines in allergy and asthma.
    Williams TJ; Jose PJ
    Chem Immunol; 2000; 78():166-77. PubMed ID: 12847728
    [No Abstract]   [Full Text] [Related]  

  • 15. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
    Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
    Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR3 blockade as a new therapy for asthma.
    Bertrand CP; Ponath PD
    Expert Opin Investig Drugs; 2000 Jan; 9(1):43-52. PubMed ID: 11060659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular allergies].
    Messmer EM
    Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.